Overview

An Efficacy and Safety Study for Nesiritide in Heart Failure Patients With Reduced Kidney Function Undergoing Coronary Artery Bypass Graft Surgery Requiring Cardiopulmonary Bypass (CPB Pump or Heart Lung Machine)

Status:
Withdrawn

Trial end date:
2009-09-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess whether nesiritide compared to placebo when given with standard of care therapies, helps preserve kidney function in heart failure (HF) patients undergoing heart bypass graft surgery that requires the use of a cardiopulmonary bypass machine (CPB pump or heart-lung machine).

Phase:

Phase 3

Details

Lead Sponsor:

Scios, Inc.

Treatments:

Natriuretic Peptide, Brain